ALNY
Alnylam Pharmaceuticals, Inc.
🇺🇸 NYSE/NASDAQ
📈 HIGH PRICE GROWTH
👑 Overview
📈 Performance
💵 Cost
🍃 Esg
🤓 Advanced
👨👩👧👦 Community
📈
+ 18.24%
Annual Growth
5 years average annual growth
🌏
3
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Alnylam Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is engaged in discovering, developing, manufacturing and commercializing novel therapeutics based on ribonucleic acid interference (RNAi). Its marketed products include AMVUTTRA (vutrisiran) for the treatment of hereditary transthyretin-mediated amyloidosis (hATTR) with polyneuropathy in adults; ONPATTRO (patisiran) for the treatment of the polyneuropathy of hATTR amyloidosis in adults; GIVLAARI (givosiran) for the treatment of adults with acute hepatic porphyria; OXLUMO (lumasiran) for the treatment of primary hyperoxaluria type 1, and Leqvio (inclisiran), which is being developed and commercialized by its partner, Novartis AG, for the treatment of adults with hypercholesterolemia or mixed dyslipidemia. The Company’s clinical development programs include Cemdisiran, Fitusiran, Zilebesiran, Elebsiran, Mivelsiran and ALN-HTT02. It is developing Cemdisiran to treat complement-mediated diseases.
📈 Performance
Price History*
+144.96%
1M
1Y
10Y
Graph
Table
* US price history does not take into account stock splits
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$250.59
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in ALNY
3
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
29 weeks
💵 Average investment amount
$598
⏰ Last time a customer invested in ALNY
103 days
ALNY investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
33%
50k - 100k
67%
Less than 50k
👶 Age of investors
18 - 25
26 - 34
33%
35 - 90
67%
🙋 Legal gender of investors
Female
67%
Male
33%
Pearlers who invest in ALNY also invest in...
🙌 Performance (5Yr p.a)
16.00%
📊 Share price
$551.75 USD
📈 HIGH PRICE GROWTH
🙌 Performance (5Yr p.a)
12.98%
📊 Share price
$50.75 USD
📈 HIGH PRICE GROWTH
🙌 Performance (5Yr p.a)
29.58%
📊 Share price
$224.18 USD
📈 HIGH PRICE GROWTH
Want more shares? Try these...
